Relmada Therapeutics
Price & Volume
Stats
See more52W Range | $3.07-$8 |
Market Cap | $421.3M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.91 |
News
See moreYahoo Finance • 2 days ago
Relmada outlines NDV-01 IND submission by year-end 2026 with cash runway through 2029
Yahoo Finance • 4 months ago
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
Yahoo Finance • 6 months ago
After-Hours Earnings Report for May 12, 2026 : FNV, NXT, OKLO, KRMN, REZI, ATRO, CAPR, AIP, EVLV, KURA, RLMD, GAIN
Yahoo Finance • 6 months ago
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
About
CEO | Dr. Sergio Traversa M.B.A., Pharm.D. |
Address | 2222 Ponce de Leon Blvd., Coral Gables, FL, United States, 33134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |